The American Macular Degeneration Foundation supports a diverse portfolio of research investigations to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD.
A new approach to gene therapy resets cell homeostasis. Clinical trials to treat the retinal disorders Retinitis Pigmentosa, Stargardt's, and Geographic Atrophy (late dry macular degeneration) are underway and showing promise.
Millions face vision loss from AMD, yet access to crucial services, assistive devices, and care remain a hurdle. AMDF declares the 4th week of February Access in Sight! AMD Advocacy and Action Week (Feb 25th-29th) to mobilize efforts and demand change for the macular degeneration and low vision community. #AccessinSight
AMDF and TLI launch a campaign to raise awareness about macular degeneration with the official release of a short film featuring TLI fellow Laura Carabello.
A 2024 AMD Awareness Month Resource Page, designed for the public and journalists, offers educational content, shareable talking points, fact sheets, shareable social media graphics, videos, opportunities for action, and more.
The American Macular Degeneration Foundation will be hosting multiple, awareness-spreading activities throughout February, which is AMD Awareness Month, including new films on living well with AMD.
The foundation is investing $1.1 million in studies that hold the potential to set new standards in the prevention and treatment of age-related macular degeneration
Science-based recipes for reducing the risk of macular degeneration progression (the AMD Diet), along with safe, low vision cooking practices
Awards will cover essential costs for young macular degeneration investigators.
A new corneal laser procedure for vision improvement in patients with late-stage, dry or wet age-related macular degeneration and other retinal disorders allows patients to regain several lines of useful vision, to read again, and to experience improved quality of life
Patients with age-related macular degeneration (AMD) who become infected with SARS-CoV-2, the virus that causes COVID-19, are at higher risk of developing severe complications including requiring supplemental oxygen and death.
Answers from trusted sources regarding macular degeneration care during the COVID-19 outbreak.
Eye research funders come together to foster research to treat age-related macular degeneration.
Vision research foundations combine resources to support macular degeneration investigations with the potential to produce new treatments.
The American Macular Degeneration Foundation (AMDF) and The Angiogenesis Foundation are partnering in a series of national initiatives designed to help people with age-related macular degeneration (AMD) get better care and treatment.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
